Lafranca Jeffrey A, van Bruggen Mark, Kimenai Hendrikus J A N, Tran Thi C K, Terkivatan Türkan, Betjes Michiel G H, IJzermans Jan N M, Dor Frank J M F
Department of Surgery, division of HPB & Transplant Surgery, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
PLoS One. 2016 Apr 14;11(4):e0153460. doi: 10.1371/journal.pone.0153460. eCollection 2016.
Whether vascular multiplicity should be considered as contraindication and therefore 'extended donor criterion' is still under debate.
Data from all live kidney donors from 2006-2013 (n = 951) was retrospectively reviewed. Vascular anatomy as imaged by MRA, CTA or other modalities was compared with intraoperative findings. Furthermore, the influence of vascular multiplicity on outcome of donors and recipients was studied.
In 237 out of 951 donors (25%), vascular multiplicity was present. CTA had the highest accuracy levels regarding vascular anatomy assessment. Regarding outcome of donors with vascular multiplicity, warm ischemia time (WIT) and skin-to-skin time were significantly longer if arterial multiplicity (AM) was present (5.1 vs. 4.0 mins and 202 vs. 178 mins). Skin-to-skin time was significantly longer, and complication rates were higher in donors with venous multiplicity (203 vs. 180 mins and 17.2% vs. 8.4%). Outcome of renal transplant recipients showed a significantly increased WIT (30 vs. 26.7 minutes), higher rate of DGF (13.9% vs. 6.9%) and lower rate of BPAR (6.9% vs. 13.9%) in patients receiving a kidney with AM compared to kidneys with singular anatomy.
We conclude that vascular multiplicity should not be a contra-indication, since it has little impact on clinical outcome in the donor as well as in renal transplant recipients.
血管多样性是否应被视为禁忌证,进而作为“扩大供体标准”,仍存在争议。
回顾性分析2006年至2013年所有活体肾供体(n = 951)的数据。将磁共振血管造影(MRA)、CT血管造影(CTA)或其他检查方式所显示的血管解剖结构与术中所见进行比较。此外,研究血管多样性对供体和受体结局的影响。
951名供体中有237名(25%)存在血管多样性。CTA在血管解剖结构评估方面准确性最高。对于存在血管多样性的供体,若存在动脉多样性(AM),热缺血时间(WIT)和皮肤对皮肤时间显著延长(分别为5.1分钟对4.0分钟和202分钟对178分钟)。存在静脉多样性的供体,其皮肤对皮肤时间显著延长,并发症发生率更高(分别为203分钟对180分钟和17.2%对8.4%)。与接受单一解剖结构肾脏的患者相比,接受具有AM的肾脏的肾移植受者的WIT显著增加(30分钟对26.7分钟),延迟性移植肾功能恢复(DGF)发生率更高(13.9%对6.9%),移植肾功能延迟恢复(BPAR)发生率更低(6.9%对13.9%)。
我们得出结论,血管多样性不应成为禁忌证,因为它对供体以及肾移植受者的临床结局影响较小。